Company / SG&A per Share
4D Molecular Therapeutics, Inc. SG&A per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.02
FY2025
5-year range
$0.65 / $1.02
FY2021-FY2025
Trend
+20.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has fluctuated over the past 6 years, ranging from $0.65 in FY2021 to $2.68 in FY2020.
Based on SEC 10-K filings.
1.02 in FY2025 with a 5-year CAGR of -17.6%.
Remained stable around $1.02 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +5.4%
- 5-Year CAGR
- -17.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share increased 20.1% year-over-year.
- Peak sg&a per share was recorded in FY2020.
- Lowest sg&a per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.26 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.02 | +20.1% |
| FY2024 | $0.85 | -16.0% |
| FY2023 | $1.01 | +16.0% |
| FY2022 | $0.87 | +34.5% |
| FY2021 | $0.65 | -75.9% |
| FY2020 | $2.68 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026